Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nevus, Pigmented | 23 | 2025 | 58 | 3.860 |
Why?
|
| Skin Neoplasms | 31 | 2025 | 620 | 2.960 |
Why?
|
| Ear, External | 5 | 2011 | 24 | 0.960 |
Why?
|
| Surgical Flaps | 18 | 2009 | 252 | 0.940 |
Why?
|
| Tissue Expansion | 12 | 2009 | 18 | 0.880 |
Why?
|
| Facial Neoplasms | 4 | 2009 | 26 | 0.540 |
Why?
|
| Ear Deformities, Acquired | 3 | 2011 | 3 | 0.480 |
Why?
|
| Infant | 31 | 2021 | 3220 | 0.450 |
Why?
|
| Skin Transplantation | 9 | 2018 | 191 | 0.430 |
Why?
|
| Child, Preschool | 25 | 2021 | 3829 | 0.430 |
Why?
|
| Child | 28 | 2021 | 7355 | 0.430 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2011 | 8 | 0.350 |
Why?
|
| Ear Auricle | 1 | 2009 | 2 | 0.310 |
Why?
|
| Eyelid Neoplasms | 1 | 2009 | 7 | 0.310 |
Why?
|
| Facial Muscles | 3 | 2003 | 24 | 0.300 |
Why?
|
| Ear Cartilage | 3 | 2009 | 4 | 0.290 |
Why?
|
| Leg | 2 | 2009 | 140 | 0.280 |
Why?
|
| Humans | 64 | 2025 | 93515 | 0.270 |
Why?
|
| Surgery, Plastic | 5 | 1990 | 38 | 0.260 |
Why?
|
| Cicatrix | 4 | 2021 | 74 | 0.250 |
Why?
|
| Melanoma | 4 | 2018 | 495 | 0.250 |
Why?
|
| Macrostomia | 2 | 2002 | 2 | 0.230 |
Why?
|
| Upper Extremity | 1 | 2005 | 64 | 0.220 |
Why?
|
| Lower Extremity | 1 | 2005 | 99 | 0.220 |
Why?
|
| Esthetics | 4 | 2009 | 50 | 0.210 |
Why?
|
| Nevus | 3 | 2009 | 18 | 0.210 |
Why?
|
| Skin Diseases | 2 | 2001 | 174 | 0.210 |
Why?
|
| Mandibular Advancement | 1 | 2003 | 6 | 0.200 |
Why?
|
| Facial Asymmetry | 1 | 2003 | 13 | 0.200 |
Why?
|
| Micrognathism | 1 | 2003 | 11 | 0.200 |
Why?
|
| Osteogenesis, Distraction | 1 | 2003 | 29 | 0.200 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2003 | 2 | 0.200 |
Why?
|
| Absorbable Implants | 1 | 2003 | 37 | 0.200 |
Why?
|
| Tissue Expansion Devices | 4 | 2009 | 7 | 0.180 |
Why?
|
| Scalp | 4 | 2004 | 70 | 0.170 |
Why?
|
| Hamartoma | 1 | 2001 | 33 | 0.170 |
Why?
|
| Neurocutaneous Syndromes | 2 | 2018 | 12 | 0.170 |
Why?
|
| Neurilemmoma | 1 | 2021 | 37 | 0.160 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 107 | 0.160 |
Why?
|
| Cleft Lip | 4 | 1984 | 16 | 0.160 |
Why?
|
| Male | 32 | 2021 | 44557 | 0.160 |
Why?
|
| Female | 32 | 2018 | 48702 | 0.150 |
Why?
|
| Lymphangioma | 2 | 1994 | 15 | 0.150 |
Why?
|
| Skin | 5 | 2016 | 578 | 0.150 |
Why?
|
| Melanosis | 1 | 2018 | 6 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 2 | 2015 | 80 | 0.140 |
Why?
|
| Quinolines | 1 | 2018 | 85 | 0.130 |
Why?
|
| Hand | 2 | 2004 | 143 | 0.130 |
Why?
|
| Free Tissue Flaps | 1 | 2018 | 54 | 0.130 |
Why?
|
| Adolescent | 13 | 2014 | 9606 | 0.130 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 1997 | 9 | 0.130 |
Why?
|
| Cleft Palate | 3 | 1988 | 27 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 446 | 0.130 |
Why?
|
| Postoperative Complications | 6 | 2011 | 2562 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 215 | 0.120 |
Why?
|
| Eczema | 1 | 2016 | 10 | 0.120 |
Why?
|
| Contracture | 2 | 2008 | 18 | 0.120 |
Why?
|
| Scrotum | 2 | 2007 | 14 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2018 | 331 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 457 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2016 | 93 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2016 | 65 | 0.120 |
Why?
|
| Th2 Cells | 1 | 2016 | 149 | 0.120 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 31 | 0.110 |
Why?
|
| Cartilage | 4 | 2009 | 115 | 0.110 |
Why?
|
| Syndactyly | 1 | 1994 | 13 | 0.110 |
Why?
|
| Benzimidazoles | 1 | 2015 | 112 | 0.110 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 1994 | 18 | 0.110 |
Why?
|
| Genital Neoplasms, Male | 1 | 1994 | 9 | 0.110 |
Why?
|
| Burns | 2 | 1993 | 149 | 0.100 |
Why?
|
| Mast Cells | 1 | 2014 | 96 | 0.100 |
Why?
|
| Rhinoplasty | 3 | 2003 | 33 | 0.100 |
Why?
|
| Mouth | 2 | 1984 | 45 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 162 | 0.100 |
Why?
|
| Psoriasis | 1 | 2016 | 254 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2021 | 1691 | 0.100 |
Why?
|
| Treatment Outcome | 6 | 2023 | 9099 | 0.100 |
Why?
|
| Apoptosis | 2 | 2018 | 1721 | 0.100 |
Why?
|
| Sweat Gland Neoplasms | 1 | 1992 | 7 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2015 | 1264 | 0.090 |
Why?
|
| Graft Survival | 2 | 2018 | 937 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 813 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2009 | 3830 | 0.080 |
Why?
|
| Muscles | 2 | 1988 | 184 | 0.080 |
Why?
|
| Bone Transplantation | 2 | 2018 | 79 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2018 | 1741 | 0.080 |
Why?
|
| Adult | 9 | 2021 | 27918 | 0.080 |
Why?
|
| Algorithms | 3 | 2008 | 1953 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2009 | 71 | 0.080 |
Why?
|
| Palatal Muscles | 1 | 1988 | 1 | 0.070 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 1988 | 3 | 0.070 |
Why?
|
| Palate | 1 | 1988 | 7 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 61 | 0.070 |
Why?
|
| Reoperation | 2 | 2008 | 702 | 0.070 |
Why?
|
| Extremities | 3 | 2004 | 176 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 2 | 2001 | 1073 | 0.070 |
Why?
|
| Connective Tissue | 1 | 1988 | 22 | 0.070 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 1988 | 17 | 0.070 |
Why?
|
| Epidermis | 1 | 1988 | 103 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2009 | 270 | 0.060 |
Why?
|
| Hypospadias | 1 | 2007 | 6 | 0.060 |
Why?
|
| Nose | 3 | 1989 | 95 | 0.060 |
Why?
|
| Mutation | 2 | 2015 | 4272 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2009 | 10164 | 0.060 |
Why?
|
| Cysts | 1 | 1987 | 99 | 0.060 |
Why?
|
| Wound Healing | 1 | 2008 | 373 | 0.060 |
Why?
|
| Abdominal Muscles | 1 | 2005 | 23 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 1028 | 0.060 |
Why?
|
| Pediatrics | 1 | 1990 | 385 | 0.060 |
Why?
|
| Methods | 3 | 1994 | 139 | 0.060 |
Why?
|
| Forehead | 2 | 2002 | 14 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 2441 | 0.050 |
Why?
|
| Neck | 1 | 2004 | 98 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2009 | 1120 | 0.050 |
Why?
|
| Nasal Septum | 1 | 2003 | 27 | 0.050 |
Why?
|
| Cheek | 1 | 2023 | 19 | 0.050 |
Why?
|
| Face | 1 | 2004 | 109 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2015 | 784 | 0.050 |
Why?
|
| Dermatofibrosarcoma | 1 | 2003 | 13 | 0.050 |
Why?
|
| Cartilage Diseases | 1 | 2003 | 18 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2009 | 3054 | 0.050 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2002 | 5 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 67 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2003 | 94 | 0.050 |
Why?
|
| Mandible | 1 | 2003 | 126 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2003 | 141 | 0.050 |
Why?
|
| Age Factors | 3 | 2016 | 1906 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2002 | 142 | 0.040 |
Why?
|
| Prostheses and Implants | 4 | 1989 | 123 | 0.040 |
Why?
|
| Syndrome | 3 | 2003 | 437 | 0.040 |
Why?
|
| Epidermal Cyst | 1 | 1980 | 7 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 253 | 0.040 |
Why?
|
| Family | 1 | 2021 | 324 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2023 | 1006 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 1992 | 2479 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2018 | 41 | 0.040 |
Why?
|
| Pyridazines | 1 | 2018 | 21 | 0.040 |
Why?
|
| Perineum | 2 | 2002 | 37 | 0.030 |
Why?
|
| Melanocytes | 2 | 2014 | 60 | 0.030 |
Why?
|
| Dermoid Cyst | 2 | 1988 | 15 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 210 | 0.030 |
Why?
|
| Nose Neoplasms | 2 | 1988 | 36 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1799 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 366 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2015 | 4560 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 3502 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1448 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1847 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 293 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 308 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1980 | 1077 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 543 | 0.020 |
Why?
|
| Buttocks | 1 | 1992 | 10 | 0.020 |
Why?
|
| Thigh | 1 | 1992 | 41 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 863 | 0.020 |
Why?
|
| Craniofacial Dysostosis | 1 | 1991 | 12 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 1 | 1991 | 19 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 1991 | 37 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1992 | 124 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 1546 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1866 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 1780 | 0.020 |
Why?
|
| Mandibular Fractures | 1 | 1989 | 7 | 0.020 |
Why?
|
| Speech Articulation Tests | 1 | 1988 | 1 | 0.020 |
Why?
|
| Speech Disorders | 1 | 1988 | 17 | 0.020 |
Why?
|
| Otitis Media | 1 | 1988 | 20 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1989 | 113 | 0.020 |
Why?
|
| Catheterization | 1 | 1989 | 218 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 1988 | 18 | 0.020 |
Why?
|
| Body Surface Area | 1 | 1988 | 36 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2544 | 0.020 |
Why?
|
| Fibroma | 1 | 1988 | 30 | 0.020 |
Why?
|
| Penis | 1 | 2007 | 61 | 0.020 |
Why?
|
| Swine | 1 | 1988 | 588 | 0.020 |
Why?
|
| Collagen | 1 | 1988 | 304 | 0.020 |
Why?
|
| Fistula | 1 | 1986 | 42 | 0.010 |
Why?
|
| Recurrence | 1 | 1988 | 1190 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1984 | 11 | 0.010 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1984 | 15 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1984 | 33 | 0.010 |
Why?
|
| Radiography | 2 | 1986 | 790 | 0.010 |
Why?
|
| Leiomyoma | 1 | 1988 | 211 | 0.010 |
Why?
|
| Angiography | 1 | 1984 | 192 | 0.010 |
Why?
|
| United States | 1 | 2016 | 7622 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 75 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 20434 | 0.010 |
Why?
|
| Mohs Surgery | 1 | 2003 | 27 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1982 | 4 | 0.010 |
Why?
|
| Malocclusion | 1 | 1982 | 7 | 0.010 |
Why?
|
| Orthodontic Appliances | 1 | 1982 | 7 | 0.010 |
Why?
|
| Cephalometry | 1 | 1982 | 47 | 0.010 |
Why?
|
| Contraindications | 1 | 2002 | 67 | 0.010 |
Why?
|
| Maxilla | 1 | 1982 | 20 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 225 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2003 | 235 | 0.010 |
Why?
|
| Models, Biological | 1 | 1988 | 1768 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2003 | 217 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1980 | 205 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1982 | 1161 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 27573 | 0.010 |
Why?
|
| Organelles | 1 | 1994 | 56 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 439 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1994 | 603 | 0.010 |
Why?
|
| Neurofibroma | 1 | 1992 | 12 | 0.010 |
Why?
|
| Pyloric Stenosis | 1 | 1991 | 8 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1991 | 46 | 0.010 |
Why?
|
| Animals | 2 | 1988 | 28155 | 0.010 |
Why?
|
| Dental Occlusion, Traumatic | 1 | 1989 | 1 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1994 | 2850 | 0.000 |
Why?
|
| Calcium Chloride | 1 | 1984 | 11 | 0.000 |
Why?
|
| Food, Formulated | 1 | 1984 | 25 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 2391 | 0.000 |
Why?
|
| Necrosis | 1 | 1984 | 204 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1984 | 284 | 0.000 |
Why?
|
| Rabbits | 1 | 1984 | 618 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1988 | 2585 | 0.000 |
Why?
|
| Time Factors | 1 | 1984 | 5410 | 0.000 |
Why?
|